FlightPath (Drug Discovery)

Berkeley, CA · Founded 2019 · Privately Held (backing)

Developer of antibiotic therapies designed to treat pathogen-driven diseases. FlightPath (Drug Discovery) is based in Berkeley, CA and was founded in 2019. Its last known valuation is $21 million. It has raised $9.7 million.

Last price · $/share
—
Implied valuation
$21.0M
Total raised
$9.7M
Last round
—

Who backs FlightPath (Drug Discovery)?

8 investors
InvestorType
Michigan RiseVenture capital
Invest Detroit VenturesVenture capital
Break Off Capital—
Ann Arbor SPARK—
First In Ventures—
Illumina—
Northern Michigan Angels—
Red Cedar Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

FlightPath (Drug Discovery) investors

8 investors are on record for FlightPath (Drug Discovery), including Michigan Rise, Invest Detroit Ventures, Break Off Capital and Ann Arbor SPARK.

Private Market View
More of FlightPath (Drug Discovery) with a free Private Market View account
  • ·Watch FlightPath (Drug Discovery): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like FlightPath (Drug Discovery). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View